HDAC6 and Parkinson disease: Interestingly, venlafaxine, in the clinical treatment of depression, was found to inhibit HDAC6 expression and then enhance α-synuclein clearance via the activation of the ubiquitin–proteasome system (UPS) and autophagy in a rotenone-induced mice model of PD [117].